We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Noninvasive Test Detects Malaria Infection without Blood Sample

By LabMedica International staff writers
Posted on 07 Aug 2023

Malaria which poses a significant global health challenge is currently diagnosed using two methods. More...

The traditional approach involves examining blood smears under a microscope, but due to resource and expertise requirements, many regions are transitioning to rapid antigen blood tests. However, both methods lack the required sensitivity. Now, an innovative noninvasive test utilizing lasers and ultrasound shows promise as a more sensitive testing alternative for malaria.

A research team co-led by Yale School of Public Health (New Haven, CT, USA) is creating two improved prototypes of their cytophone testing platform that will undergo extensive field tests in Burkina Faso, a West African nation where malaria is endemic. Their work builds upon an earlier nonportable prototype designed to detect circulating melanoma cells non-invasively. The new portable version aims to detect malaria infections in people living in endemic areas and aid malaria interventions in Africa.

The cytophone technology employs lasers of specific wavelengths directed at superficial blood vessels. Malaria parasites, upon entering red blood cells, liberate amino acids using hemoglobin. This process releases hemozoin, a compound containing iron. Upon being hit by a laser, hemozoin absorbs more of the energy than hemoglobin, leading to greater energy absorption in malaria-infected cells. As a result, acoustic waves are generated due to heat expansion that is detected by the cytophone technology using a small ultrasound transducer placed on the skin. Through software analysis, peaks in the acoustic waves can identify malaria infections.

Previous studies have demonstrated the device's ability to identify infections in mice using rodent species of malaria parasites and in human blood infected with malaria parasites. Subsequently, a portable version of the device was developed, and a proof-of-concept study was conducted on malaria-infected adults in Cameroon, yielding promising results. However, some unanswered questions remained, prompting the need for improvements in durability, precision, and operational complexity. The researchers also intended to extend their clinical work to study asymptomatic infections, including those in children.

Using a USD 500,000 grant received from the Gates Foundation, the research team plans to build two new, smaller, and more advanced prototypes of the device. These upgraded versions will incorporate improved ultrasound, laser, and software processing capabilities. In collaboration with partners in Burkina Faso, the team will conduct clinical studies to validate the technology's effectiveness in diagnosing malaria in both infected and uninfected adults, including school-aged children with symptomatic malaria. The aim is to fine-tune the device to ensure accurate data acquisition and understand potential causes of false positive or negative results. Ultimately, this technology could lead to significant advancements in diagnosing, treating, and comprehending malaria, as it has the potential to be far more sensitive than current diagnostic tests.

Additionally, the cytophone technology could address an emerging issue with certain antigen tests. In Africa, common antigen tests target an antigen found in Plasmodium falciparum, the most dangerous of the five species of malaria-causing protozoa. However, researchers have encountered parasites with deletions of this antigen, which compromises the accuracy of such tests. Since the cytophone relies on hemozoin, a marker produced by all species of malaria parasites during their life cycle, it avoids this problem. Moreover, the technology's focus on hemozoin could aid researchers in developing and studying new antimalarial drugs targeting this pathway in humans, noninvasively, which is crucial for combating parasite resistance to medications in the long run.

Related Links:
Yale School of Public Health


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.